Baseline patient characteristics
| Variable . | Overall (N = 1635) . |
|---|---|
| Mean age ± SD | 56.17 ± 16.16 |
| Male sex | 986 (60.3) |
| Symptomatic patients | 950 (58.1) |
| Involved vein | |
| Portal vein | 562 (34.4) |
| Mesenteric vein | 217 (13.3) |
| Budd-Chiari syndrome | 201 (12.3) |
| Splenic vein | 107 (6.5) |
| Multiple veins | 548 (33.5) |
| Risk factors | |
| Unprovoked | 462 (28.3) |
| Solid cancer | 523 (32.0) |
| Liver cirrhosis | 287 (17.6) |
| Myeloproliferative neoplasm | 118 (7.2) |
| Recent surgery | 155 (9.5) |
| Hormonal therapy | 57 (3.5) |
| Inflammatory bowel disease | 24 (1.5) |
| Pregnancy or puerperium | 15 (0.9) |
| Pancreatitis/abdominal infection | 155 (7.0) |
| Leukemia, lymphoma, myeloma | 20 (1.2) |
| Thrombophilia | |
| Tested negative | 186 (11.4) |
| Tested positive | 281 (17.2) |
| Laboratory test results | |
| Hemoglobin ≤10 g/dL* | 284 (17.4) |
| Platelets* | |
| ≤100 × 103/mm3 | 255 (15.6) |
| ≤50 × 103/mm3 | 60 (3.7) |
| Anticoagulant therapy | |
| None | 325 (19.8) |
| LMWH alone | 521 (31.9) |
| VKAs alone | 416 (25.4) |
| DOACs alone | 27 (1.7) |
| UFH alone | 8 (0.5) |
| Fondaparinux alone | 17 (1.0) |
| Multiple agents | 321 (19.6) |
| Variable . | Overall (N = 1635) . |
|---|---|
| Mean age ± SD | 56.17 ± 16.16 |
| Male sex | 986 (60.3) |
| Symptomatic patients | 950 (58.1) |
| Involved vein | |
| Portal vein | 562 (34.4) |
| Mesenteric vein | 217 (13.3) |
| Budd-Chiari syndrome | 201 (12.3) |
| Splenic vein | 107 (6.5) |
| Multiple veins | 548 (33.5) |
| Risk factors | |
| Unprovoked | 462 (28.3) |
| Solid cancer | 523 (32.0) |
| Liver cirrhosis | 287 (17.6) |
| Myeloproliferative neoplasm | 118 (7.2) |
| Recent surgery | 155 (9.5) |
| Hormonal therapy | 57 (3.5) |
| Inflammatory bowel disease | 24 (1.5) |
| Pregnancy or puerperium | 15 (0.9) |
| Pancreatitis/abdominal infection | 155 (7.0) |
| Leukemia, lymphoma, myeloma | 20 (1.2) |
| Thrombophilia | |
| Tested negative | 186 (11.4) |
| Tested positive | 281 (17.2) |
| Laboratory test results | |
| Hemoglobin ≤10 g/dL* | 284 (17.4) |
| Platelets* | |
| ≤100 × 103/mm3 | 255 (15.6) |
| ≤50 × 103/mm3 | 60 (3.7) |
| Anticoagulant therapy | |
| None | 325 (19.8) |
| LMWH alone | 521 (31.9) |
| VKAs alone | 416 (25.4) |
| DOACs alone | 27 (1.7) |
| UFH alone | 8 (0.5) |
| Fondaparinux alone | 17 (1.0) |
| Multiple agents | 321 (19.6) |
Values in parentheses are percentages.
SD, standard deviation; UFH, unfractionated heparin.
Measurements in 104 patients were missing.